Featured Content

More News

Sector News

More News


More Articles...

Subscriber Only Content

More News

News and Analysis

More News

Newsletter

BioMedReports RestorGenex Announces Data on the Effect of RES-529; Amarantus Enters Into CRO Agreement With Chiltern Interna... http://t.co/L4WXOvjXCV
BioMedReports Theravance Biopharma Presents Additional Positive Phase 2b Study Data on TD-4208; Actinium To Provide Clinical... http://t.co/rnizhlrOs8
BioMedReports Exceptional Management and Disruptive Products Top the Investment Checklist for Vista Partners' Ross Silver: I... http://t.co/LhCzZErbXw

RSS Subscription